deferoxamine has been researched along with kt 5823 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tan, T; Weiss, HR | 1 |
| Scholz, PM; Tan, T; Weiss, HR | 1 |
2 other study(ies) available for deferoxamine and kt 5823
| Article | Year |
|---|---|
Hypoxia inducible factor-1 protects against nitrate tolerance and stunning in rabbit cardiac myocytes.
Topics: Animals; Calcium-Binding Proteins; Carbazoles; Cell Shape; Cyclic GMP-Dependent Protein Kinases; Deferoxamine; Drug Tolerance; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Models, Biological; Myocardial Contraction; Myocardial Stunning; Myocytes, Cardiac; Natriuretic Peptide, Brain; Nitroglycerin; Phosphorylation; Protein Kinase Inhibitors; Rabbits; S-Nitroso-N-Acetylpenicillamine; Up-Regulation | 2010 |
Hypoxia inducible factor-1 improves the negative functional effects of natriuretic peptide and nitric oxide signaling in hypertrophic cardiac myocytes.
Topics: Animals; Carbazoles; Cardiomegaly; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Deferoxamine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nitric Oxide; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Up-Regulation | 2010 |